A new approach to monitor expression of aldo-keto reductase proteins in mouse tissues

Proteomics

Volumn 9, Issue 22, 2009, Pages 5090-5100

  Tu, Shuyang ^a,b   Ren, Yan ^a,b   Tong, Wei ^a,b   Zheng, Shirong ^c   Xu, Ningzhi ^a,b   Bhatnagar, Aruni ^c   Liu, Siqi ^a,b,c  

^a Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^b Beijing Proteomics Institute   (China)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDO KETO REDUCTASE; ALDO KETO REDUCTASE 1B; ALDO KETO REDUCTASE 1C; ENZYME ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; OXIDOREDUCTASE; PAN AKR P1 ANTIBODY; PAN AKR P3 ANTIBODY; PAN AKR P4 ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; CONJUGATION; CONTROLLED STUDY; IMMUNOREACTIVITY; KIDNEY PARENCHYMA; LIVER; MASS SPECTROMETRY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RABBIT; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ALCOHOL OXIDOREDUCTASES; ANIMALS; BLOTTING, WESTERN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KIDNEY; LIVER; MICE; TANDEM MASS SPECTROMETRY;

MUS; ORYCTOLAGUS CUNICULUS; PATELLIDAE;

EID: 70949099308     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900256     Document Type: Article

References (37)

1. Jez, J. M., Bennett, M. J., Schlegel, B. P., Lewis, M., Penning, T. M., Comparative anatomy of the aldo-keto reductase superfamily. Biochem. J. 1997, 326, 625-636. (Pubitemid 27438032)
2. Jin, Y., Penning, T. M., Aldo-keto reductases and bioactivation/ detoxication. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 263-292.
3. Maser, E., Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK. Trends Pharmacol. Sci. 2004, 25, 235-237. (Pubitemid 38553822)
4. Esterbauer, H., Schaur, R. J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81-128. (Pubitemid 121003917)
5. Yan, R., Zu, X., Ma, J., Liu, Z. et al., Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int. J. Cancer 2007, 121, 2301-2306. (Pubitemid 47585613)
6. Woenckhaus, M., Klein-Hitpass, L., Grepmeier, U. et al., Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers. J. Pathol. 2006, 210, 192-204. (Pubitemid 44463934)
7. Hyndman, D., Bauman, D. R., Heredia, V. V., Penning, T. M., The aldo-keto reductase superfamily homepage. Chem. Biol. Interact. 2003, 143- 144, 621-631.
8. O'Connor, T., Ireland, L. S., Harrison, D. J., Hayes, J. D., Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem. J. 1999, 343, 487-504. (Pubitemid 29511786)
9. Alary, J., Gueraud, F., Cravedi, J. P., Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol. Aspects Med. 2003, 24, 177-187. (Pubitemid 36945018)
10. Shinmura, K., Bolli, R., Liu, S. Q., Tang, X. L. et al., Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ. Res. 2002, 91, 240-246. (Pubitemid 34875679)
11. Vander Jagt, D. L., Kolb, N. S., Vander Jagt, T. J., Chino, J. et al., Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim. Biophys. Acta 1995, 1249, 117-126.
12. Burczynski, M. E., Sridhar, G. R., Palackal, N. T., Penning, T. M., The reactive oxygen species - and Michael acceptor - inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. J. Biol. Chem. 2001, 276, 2890-2897. (Pubitemid 37376672)
13. Martin, H. J., Maser, E., Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes. Chem. Biol. Interact. 2009, 178, 145-150.
14. Penning, T. M., Jin, Y., Steckelbroeck, S., Lanisnik Rizner, T., Lewis, M., Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins. Mol. Cell Endocrinol. 2004, 215, 63-72. (Pubitemid 38337424)
15. Chang, Q., Petrash, J. M., Disruption of aldo-keto reductase genes leads to elevated markers of oxidative stress and inositol auxotrophy in Saccharomyces cerevisiae. Biochim. Biophys. Acta 2008, 1783, 237-245.
16. Ho, H. T., Chung, S. K., Law, J. W., Ko, B. C. et al., Aldose reductase-deficient mice develop nephrogenic diabetes insipidus. Mol. Cell Biol. 2000, 20, 5840-5846. (Pubitemid 30613033)
17. Kolaskar, A. S., Tongaonkar, P. C., A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990, 276, 172-174.
18. Epstein, P. N., Overbeek, P. A., Means, A. R., Calmodulin-induced early-onset diabetes in transgenic mice. Cell 1989, 58, 1067-1073.
19. Rose, A. J., Michell, B. J., Kemp, B. E., Hargreaves, M., Effect of exercise on protein kinase C activity and localization in human skeletal muscle. J. Physiol. 2004, 561, 861-870. (Pubitemid 40074940)
20. Volmer, R., Monnet, C., Gonzalez-Dunia, D., Borna disease virus blocks potentiation of presynaptic activity through inhibition of protein kinase C signaling. PLoS Pathog. 2006, 2, e19.
21. Bandyopadhyay, G., Biswas, T., Roy, K. C., Mandal, S. et al., Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood 2004, 104, 2514-2522. (Pubitemid 39331855)
22. Duijvestijn, A. M., Kerkhove, M., Bargatze, R. F., Butcher, E. C., Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies. J. Immunol. 1987, 138, 713-719. (Pubitemid 17012383)
23. Garnier, J., Gibrat, J. F., Robson, B., GOR method for predicting protein secondary structure from amino acid sequence. Meth. Enzymol. 1996, 266, 540-553. (Pubitemid 26165888)
24. McCormick, C. C., Fullmer, C. S., Garvey, J. S., Amino acid sequence and comparative antigenicity of chicken metallothionein. Proc. Natl. Acad. Sci. USA 1988, 85, 309-313.
25. Debelle, L., Wei, S. M., Jacob, M. P., Hornebeck, W., Alix, A. J., Predictions of the secondary structure and antigenicity of human and bovine tropoelastins. Eur. Biophys. J. 1992, 21, 321-329. (Pubitemid 23010566)
26. Penning, T. M., Burczynski, M. E., Jez, J. M., Hung, C. F. et al., Human 3 alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J. 2000, 351, 67-77.
27. Allan, D., Lohnes, D., Cloning and developmental expression of mouse aldehyde reductase (AKR1A4). Mech. Dev. 2000, 94, 271-275. (Pubitemid 30332415)
28. Nishimura, C., Graham, C., Hohman, T. C., Nagata, M. et al., Characterization of mRNA and genes for aldose reductase in rat. Biochem. Biophys. Res. Commun. 1988, 153, 1051-1059. (Pubitemid 18174603)
29. Vergnes, L., Phan, J., Stolz, A., Reue, K., A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13. J. Lipid Res. 2003, 44, 503-511. (Pubitemid 37287563)
30. Lau, E. T., Cao, D., Lin, C., Chung, S. K., Chung, S. S., Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland. Biochem. J. 1995, 312, 609-615. (Pubitemid 26002232)
31. Matsumoto, K., Endo, S., Ishikura, S., Matsunaga, T. et al., Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. Biol. Pharm. Bull. 2006, 29, 539-542.
32. Ferraris, J. D., Williams, C. K., Jung, K. Y., Bedford, J. J. et al., ORE, a eukaryotic minimal essential osmotic response element. The aldose reductase gene in hyperosmotic stress. J. Biol. Chem. 1996, 271, 18318-18321. (Pubitemid 26322681)
33. Bagnasco, S. M., Uchida, S., Balaban, R. S., Kador, P. F., Burg, M. B., Induction of aldose reductase and sorbitol in renal inner medullary cells by elevated extracellular NaCl. Proc. Natl. Acad. Sci. USA 1987, 84, 1718-1720. (Pubitemid 17066759)
34. Yabe-Nishimura, C., Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 1998, 50, 21-33. (Pubitemid 28158840)
35. Zheng, S ., Noonan, W. T., Metreveli, N. S., Coventry, S. et al., Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 2004, 53, 3248-3257. (Pubitemid 39564502)
36. Shen, X., Ye, G., Metreveli, N. S., Epstein, P. N., Cardiomyocyte defects in diabetic models and protection with cardiac-targeted transgenes. Meth. Mol. Med. 2005, 112, 379-388.
37. Kashiba, M., Oka, J., Ichikawa, R., Kageyama, A., Impaired reductive regeneration of ascorbic acid in the Goto-Kakizaki diabetic rat. Biochem. J. 2000, 351 313-318. (Pubitemid 30825592)